XML 37 R27.htm IDEA: XBRL DOCUMENT
v3.21.2

Note 19 - Concentration of Risk | 6 Months Ended
--- | ---
Jun. 30, 2021
Notes to Financial Statements |
Concentration Risk Disclosure [Text Block] |
19. |  | Concentration of risk
Credit risk Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents, accounts receivable, and deposits and loans to unrelated parties. As of June 30, 2021, 41% of the Company’s cash and cash equivalents were held by major financial institutions located in Mainland and Hong Kong, China, the remaining 59% was held by financial institutions located in the United States of America. The Company believes that these financial institutions located in China and the United States of America are of high credit quality. For accounts receivable and deposits and loans to unrelated parties, the Company extends credit based on an evaluation of the customer’s or other parties’ financial condition, generally without requiring collateral or other security. In order to minimize the credit risk, the Company delegated a team responsible for credit approvals and other monitoring procedures to ensure that follow-up action is taken to recover overdue debts. Further, the Company reviews the recoverable amount of each individual receivable at each balance sheet date to ensure that adequate allowances are made for doubtful accounts. In this regard, the Company considers that the Company’s credit risk for accounts receivable and deposits and loans to unrelated parties are significantly reduced. Concentration of customers The following tables summarized the information about the Company’s concentration of customers for the six and three months ended June 30, 2021 and 2020, respectively:
|  | Customer A |  |  | Customer B |  |  | Customer C |  |  | Customer D |  |  | Customer E |  |  | Customer F |
Six Months Ended June 30, 2021 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenues, customer concentration risk |  |  | 11 | % |  |  | 14 | % |  |  | * |  |  |  | - |  |  |  | - |  |  |  | * |
Three Months Ended June 30, 2021 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenues, customer concentration risk |  |  | 14 | % |  |  | 12 | % |  |  | * |  |  |  | - |  |  |  | - |  |  |  | * |
Six Months Ended June 30, 2020 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenues, customer concentration risk |  |  | - |  |  |  | - |  |  |  | * |  |  |  | * |  |  |  | * |  |  |  | - |
Three Months Ended June 30, 2020 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenues, customer concentration risk |  |  | - |  |  |  | - |  |  |  | * |  |  |  | * |  |  |  | * |  |  |  | - |
As of June 30, 2021 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Accounts receivable, customer concentration risk |  |  | 62 | % |  |  | - |  |  |  | 17 | % |  |  | - |  |  |  | - |  |  |  | 10 | %
As of December 31, 2020 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Accounts receivable, customer concentration risk |  |  | - |  |  |  | - |  |  |  | 28 | % |  |  | 27 | % |  |  | 21 | % |  |  | - |
* Less than 10%. - No transaction incurred for the reporting period/no balance existed as of the reporting date. Concentration of suppliers The following tables summarized the information about the Company’s concentration of suppliers for the six and three months ended June 30, 2021 and 2020, respectively:
|  | Supplier A |  |  | Supplier B |
Six Months Ended June 30, 2021 |  |  |  |  |  |  |  |
Cost of revenues, supplier concentration risk |  |  | 73 | % |  |  | 12 | %
Three Months Ended June 30, 2021 |  |  |  |  |  |  |  |
Cost of revenues, supplier concentration risk |  |  | 86 | % |  |  | * |
Six Months Ended June 30, 2020 |  |  |  |  |  |  |  |
Cost of revenues, supplier concentration risk |  |  | - |  |  |  | 78 | %
Three Months Ended June 30, 2020 |  |  |  |  |  |  |  |
Cost of revenues, supplier concentration risk |  |  | - |  |  |  | 81 | %
* Less than 10%. - No transaction incurred for the reporting period/no balance existed as of the reporting date.

X
- Definition The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -URI http://asc.fasb.org/topic&trid=2134479 + Details
Name: | us-gaap_ConcentrationRiskDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration